Detoxification of organophosphate poisoning using nanoparticle bioscavengers

Summary

This study tests a circulating bioscavenger for organophosphate poisoning based on the acetylcholinesterase naturally displayed by red-blood-cell membranes. Organophosphates irreversibly inhibit this enzyme, causing acetylcholine accumulation and severe neuromuscular toxicity. The investigators coated polymeric nanoparticle cores with erythrocyte membrane so that membrane-bound acetylcholinesterase could act as a sacrificial target and intercept toxin before it disabled endogenous enzyme. In vitro, the particles retained enzymatic activity and bound the model organophosphate dichlorvos, protecting other enzyme substrates from inhibition. In dichlorvos-challenged mice, treatment improved blood acetylcholinesterase activity and markedly increased survival. The principal result is a biomimetic decoy that uses a native membrane enzyme to remove poison in the bloodstream, potentially complementing treatments directed at downstream cholinergic symptoms. This is significant because interception occurs before additional host enzyme is inactivated. However, the abstract reports no nanoparticle or dichlorvos dose, timing, binding capacity, enzyme kinetics, animal numbers, survival values, neurological outcomes, clearance, or toxicity. Only one model organophosphate was tested. Effectiveness after delayed treatment, against nerve agents or repeated exposure, and alongside standard antidotes is unknown, as are immunological safety, membrane sourcing, manufacturing, and human benefit.